raloxifén
Raloxifene is a type of medication known as a selective estrogen receptor modulator (SERM). It is primarily used to prevent and treat osteoporosis in postmenopausal women, as well as to reduce the risk of invasive breast cancer in these patients. Raloxifene works by mimicking the effects of estrogen on bone tissue, which helps to increase bone density and reduce the risk of fractures.
Raloxifene was first approved by the US FDA in 1997 under the brand name Evista. It is
The most common side effects of raloxifene include hot flashes, leg cramps, and flu-like symptoms. More serious
Raloxifene's mechanism of action involves binding to estrogen receptors in the body, which allows it to exert
General information about raloxifene is available through various medical and health organizations, including the American osteopathic